Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
阐明介导 HIV 感染者 DKD 进展的分子机制
基本信息
- 批准号:10364063
- 负责人:
- 金额:$ 85.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-01 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:AgingAnimal ModelArchivesAutomobile DrivingBiopsyCellsChronicChronic Kidney FailureClinical DataCollaborationsComplementDataData SetDevelopmentDiabetes MellitusDiabetic NephropathyDiabetic mouseDisease ProgressionDoseDoxycyclineEnd stage renal failureEpithelial CellsExposure toFormalinGene ExpressionGene Expression ProfileGenesGoalsHIVHIV InfectionsHIV SeropositivityHIV therapyHIV-1Hepatitis C virusHumanHypertensionImmuneIn Situ HybridizationInflammationInjuryInjury to KidneyKidneyKidney DiseasesKidney TransplantationKnowledgeLeukocytesLongitudinal StudiesMediatingModelingMolecularMusOnline SystemsOrganPTPRC geneParaffin EmbeddingPathway interactionsPatientsPharmaceutical PreparationsPharmacologyPlasmaPopulationPrevalenceProcessPublishingRNARegimenReportingSample SizeScientistSlideStreptozocinSystemT-LymphocyteTissuesTransgenic MiceTransgenic OrganismsTubular formationUnited StatesVeteransViral Load resultViremiaage relatedantiretroviral therapybasecohortcomorbiditydiabeticdiabetic patientefficacy validationgenetic signaturekidney biopsykidney cellmouse modelnew therapeutic targetnon-diabeticnovel therapeuticspersonalized medicinepodocyteresponsesingle-cell RNA sequencingsmall moleculetargeted treatmenttranscriptomicsweb portal
项目摘要
SUMMARY
With the aging of the HIV-infected population, and their prolonged exposure to cART regimens that may promote
the development of diabetes, the prevalence of diabetic kidney disease (DKD) is increasing in patients living with
HIV (PLWH). In two recent studies, we and others have confirmed the additive/synergistic effects of HIV infection
and diabetes on the progression of DKD. Studies have demonstrated that HIV can infect kidney cells, and that
the kidney serves as a reservoir for HIV replication. Recent findings suggest that HIV is present in the kidney
even in cART-treated HIV patients. To determine how chronic HIV infection in patients with low or undetectable
viral load aggravates DKD, we generated a doxycycline-inducible kidney cell-specific HIV transgenic mouse the
expresses low levels of HIV genes. With this model, we confirmed that low level of HIV gene expression did not
cause kidney injury alone. However, aggravated DKD was observed after induction of diabetes, suggesting an
additive/synergistic effect of HIV and diabetes on DKD progression (Feng J. Kidney Int. 2021). For this project,
we will further investigate the molecular mechanisms by which chronic HIV infection induces the progression of
DKD in both mouse models and human patients with HIV to accelerate the discovery of new drug targets and
therapeutics to treat these patients. Toward this goal, we propose the following specific aims: Aim 1: Perform
comprehensive bulk and single-cell RNA-sequencing of the kidneys and kidney immune cells from the mice with
both diabetes and low HIV gene expression as compared to control mice, and mice with HIV or diabetes alone.
Aim 2: Perform formalin fixed paraffin embedded slides-based RNA-capture sequencing, scRNA-seq,
immunostaining, and in-situ hybridization of kidneys from patients with DKD alone, and from those with both HIV
infection and DKD. Aim 3: Integrate these datasets together with publicly available datasets to identify gene
expression signatures mediating the additive/synergistic effects of HIV and diabetes on DKD progression. Utilize
the Connectivity Mapping approach to identify potential drugs and small molecules which could reverse these
gene signatures similarly to the approach described in our recent study (Zhang L. Diabetes 2020). Develop a
web-portal to serve and interact with all project data. Aim 4: Validate predicted drugs from aim 3 in the animal
model described in the aim 1. Overall, this project will enable us to identify potential new mechanisms, new drug
targets, and potential new therapeutics to halt the progression of DKD in PLWH.
概括
随着 HIV 感染人群的老龄化,以及他们长期接触 cART 治疗方案,可能会促进
随着糖尿病的发展,患有糖尿病的患者中糖尿病肾病(DKD)的患病率正在增加
艾滋病毒(艾滋病病毒感染者)。在最近的两项研究中,我们和其他人证实了艾滋病毒感染的累加/协同效应
和糖尿病对 DKD 进展的影响。研究表明,艾滋病毒可以感染肾细胞,并且
肾脏是艾滋病毒复制的储存库。最近的研究结果表明艾滋病毒存在于肾脏中
即使在接受 cART 治疗的 HIV 患者中也是如此。确定慢性 HIV 感染率低或无法检测的患者的情况
病毒载量加重 DKD,我们制备了强力霉素诱导的肾细胞特异性 HIV 转基因小鼠
表达低水平的 HIV 基因。通过这个模型,我们证实低水平的 HIV 基因表达并没有
单独造成肾损伤。然而,在诱导糖尿病后观察到 DKD 加重,这表明
HIV 和糖尿病对 DKD 进展的累加/协同作用(Feng J. Kidney Int. 2021)。对于这个项目,
我们将进一步研究慢性HIV感染诱发病情进展的分子机制
DKD 在小鼠模型和人类 HIV 患者中进行,以加速新药靶点的发现和
治疗这些患者的疗法。为了实现这一目标,我们提出以下具体目标: 目标 1:执行
对小鼠的肾脏和肾脏免疫细胞进行全面的批量和单细胞 RNA 测序
与对照小鼠以及仅患有艾滋病毒或糖尿病的小鼠相比,糖尿病和低艾滋病毒基因表达。
目标 2:执行基于福尔马林固定石蜡包埋载玻片的 RNA 捕获测序、scRNA-seq、
对单纯 DKD 患者和同时感染 HIV 患者的肾脏进行免疫染色和原位杂交
感染和 DKD。目标 3:将这些数据集与公开可用的数据集整合在一起以识别基因
介导 HIV 和糖尿病对 DKD 进展的累加/协同效应的表达特征。利用
连接映射方法来识别可以逆转这些的潜在药物和小分子
基因特征与我们最近的研究中描述的方法类似(Zhang L. Diabetes 2020)。开发一个
用于服务所有项目数据并与之交互的门户网站。目标 4:在动物身上验证目标 3 预测的药物
目标 1 中描述的模型。总体而言,该项目将使我们能够识别潜在的新机制、新药物
目标,以及阻止 PLWH 中 DKD 进展的潜在新疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John Cijiang He其他文献
Bisphenol A promotes hyperuricemia via activating xanthine oxidase
双酚A通过激活黄嘌呤氧化酶促进高尿酸血症
- DOI:
10.1096/fj.201700755r - 发表时间:
2017-10 - 期刊:
- 影响因子:0
- 作者:
Linqiang Ma;Jinbo Hu;Jiayu Li;Yi Yang;Linkun Zhang;Lingyun Zou;Rufei Gao;Yue Wang;Ting Luo;Xiaojiao Xiang;Hua Qing;Xiaoqiu Xiao;Chaodong Wu;Zhihong Wang;John Cijiang He;Qifu Li;Shumin Yang - 通讯作者:
Shumin Yang
An update: the role of Nephrin inside and outside the kidney
- DOI:
10.1007/s11427-015-4844-1 - 发表时间:
2015-04-29 - 期刊:
- 影响因子:9.500
- 作者:
XueZhu Li;John Cijiang He - 通讯作者:
John Cijiang He
A Newly Identified Protective Role of C5a Receptor 1 in Kidney Tubules against Toxin-Induced Acute Kidney Injury
新发现的C5a受体1在肾小管中对毒素诱导的急性肾损伤的保护作用
- DOI:
10.1016/j.ajpath.2024.10.003 - 发表时间:
2025-01-01 - 期刊:
- 影响因子:3.600
- 作者:
Samuel Mon-Wei Yu;Emily King;Miguel Fribourg;Susan Hartzell;Liam Tsou;Logan Gee;Vivette D. D'Agati;Joshua M. Thurman;John Cijiang He;Paolo Cravedi - 通讯作者:
Paolo Cravedi
Bisphenol A promotes hyperuricemia via activating xanthine oxidase
- DOI:
doi: 10.1096/fj.201700755R - 发表时间:
- 期刊:
- 影响因子:
- 作者:
Linqiang Ma;Jinbo Hu;Jiayu Li;Yi Yang;Linkun Zhang;Lingyun Zou;Rufei Gao;Chuan Peng;Yue Wang;Ting Luo;Xiaojiao Xiang;Hua Qing;Xiaoqiu Xiao;Chaodong Wu;Zhihong Wang;John Cijiang He;Qifu Li;Shumin Yang - 通讯作者:
Shumin Yang
RETRACTED ARTICLE: LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma
撤回文章:长链非编码 RNA HOTAIR 通过抑制肾细胞癌中的 miR-217 调节 HIF-1α/AXL 信号通路
- DOI:
10.1038/cddis.2017.181 - 发表时间:
2017-05-11 - 期刊:
- 影响因子:9.600
- 作者:
Quan Hong;Ou Li;Wei Zheng;Wen-zhen Xiao;Lu Zhang;Di Wu;Guang-yan Cai;John Cijiang He;Xiang-mei Chen - 通讯作者:
Xiang-mei Chen
John Cijiang He的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John Cijiang He', 18)}}的其他基金
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease
Vpr 介导的细胞周期失调在 HIV 相关肾病中的作用
- 批准号:
10678878 - 财政年份:2022
- 资助金额:
$ 85.86万 - 项目类别:
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease
Vpr 介导的细胞周期失调在 HIV 相关肾病中的作用
- 批准号:
10527702 - 财政年份:2022
- 资助金额:
$ 85.86万 - 项目类别:
Role of RARRES1 in diabetic kidney disease
RARRES1 在糖尿病肾病中的作用
- 批准号:
10278234 - 财政年份:2021
- 资助金额:
$ 85.86万 - 项目类别:
Role of RARRES1 in diabetic kidney disease
RARRES1 在糖尿病肾病中的作用
- 批准号:
10662465 - 财政年份:2021
- 资助金额:
$ 85.86万 - 项目类别:
Role of RARRES1 in diabetic kidney disease
RARRES1 在糖尿病肾病中的作用
- 批准号:
10461883 - 财政年份:2021
- 资助金额:
$ 85.86万 - 项目类别:
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
阐明介导 HIV 感染者 DKD 进展的分子机制
- 批准号:
10531888 - 财政年份:2021
- 资助金额:
$ 85.86万 - 项目类别:
PP2A as a drug target for diabetic kidney disease
PP2A作为糖尿病肾病的药物靶点
- 批准号:
10399582 - 财政年份:2020
- 资助金额:
$ 85.86万 - 项目类别:
PP2A as a drug target for diabetic kidney disease
PP2A作为糖尿病肾病的药物靶点
- 批准号:
10627834 - 财政年份:2020
- 资助金额:
$ 85.86万 - 项目类别:
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies
增殖性肾小球病中足细胞-壁上皮细胞串扰的介导机制
- 批准号:
10434116 - 财政年份:2020
- 资助金额:
$ 85.86万 - 项目类别:
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies
增殖性肾小球病中足细胞-壁上皮细胞串扰的介导机制
- 批准号:
10119964 - 财政年份:2020
- 资助金额:
$ 85.86万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 85.86万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 85.86万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 85.86万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 85.86万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 85.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 85.86万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 85.86万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 85.86万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 85.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 85.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




